Understanding Inventorship: Who Is — and Who Is Not — an Inventor

In everyday language, the word “inventor” tends to be used loosely — it might refer to anyone who worked on a project, contributed to a discovery, or was present in the lab when a breakthrough occurred. Patent law, however, uses the term with considerable precision, and the legal definition of inventorship is both narrower and more specific than most people expect. Under United States patent law, an inventor is someone who contributed to the conception of at least one claim in the patent application. Conception, in this legal sense, means the formation in the mind of a definite and permanent idea of the complete and operative invention — in other words, the mental act of creating the specific solution that the patent is protecting. Contributing to the reduction to practice — actually building the device, running the experiments, or synthesizing the compound — does not by itself make someone an inventor if they were simply executing someone else’s idea. Nor does supervising the work, funding the research, or suggesting the general problem to be solved. Inventorship is determined claim by claim, and it is entirely possible for different claims within the same patent to have different inventors.

Why Getting Inventorship Right Matters

Correctly identifying inventors is not merely a formality — it has significant legal and commercial consequences. While the law does allow for corrections to inventorship in many circumstances, disputes over who should have been named as an inventor can become deeply contentious, particularly when equity, royalties, or institutional rights are at stake. For life sciences startups, where foundational patents are often developed in academic or collaborative settings involving multiple researchers, postdoctoral fellows, students, and outside consultants, the risk of inventorship errors is real and worth taking seriously. Establishing a clear and documented process for evaluating inventorship — ideally with patent counsel involved from an early stage — is one of the more important administrative practices a startup can adopt.

Inventorship vs. Authorship: A Critical Distinction

One of the most common sources of confusion for scientists transitioning from academic research into the startup world is the difference between being named as an inventor on a patent and being listed as an author on a scientific publication. In academia, authorship is governed by norms of professional credit and contribution — journal guidelines typically require that authors have made meaningful contributions to the research, participated in drafting or critically revising the manuscript, and approved the final version for publication. These standards, while important to the scientific community, have no bearing whatsoever on patent inventorship. The two concepts are governed by entirely different rules and serve entirely different purposes, and the lists of inventors and authors arising from the same body of work will frequently differ — sometimes substantially.

Where the Two Lists Diverge

The divergence between inventors and authors arises from the fact that each standard asks a fundamentally different question. Authorship asks: who contributed meaningfully to this research and its communication? Inventorship asks: who conceived of the specific claimed invention? A senior scientist who designed the overall research program and secured the funding may be a natural candidate for authorship but may not have contributed to the conception of any specific patentable claim. A graduate student who ran all the experiments may be listed as an author for their laboratory contribution but may similarly not qualify as an inventor if they were following a protocol conceived by someone else. Conversely, a collaborator at another institution who contributed a key inventive idea in a single conversation may be a named inventor on a patent while receiving no authorship credit on the resulting paper. Neither outcome is incorrect — they simply reflect the application of two different standards to the same body of work.

Joint Inventorship Between Institutions

Collaborative research between a startup and one or more external institutions — a university, a hospital, a government laboratory, or another company — creates a specific category of complexity known as joint inventorship. When researchers from two or more organizations each contribute to the conception of a patentable invention, the resulting patent may name inventors from both institutions, and each institution may assert an ownership interest in proportion to the inventive contributions of its employees. Under United States patent law, each joint owner of a patent has the right to exploit the patent independently and without the consent of the other owners — a default rule that can create significant problems if left unaddressed. One co-owner could, in theory, license the technology to a competitor without sharing the proceeds, or refuse to join a lawsuit against an infringer, or assert rights in ways that directly conflict with the startup’s commercial interests. For this reason, it is essential that any collaborative research arrangement between a startup and an outside institution be governed by a written agreement — typically an inter-institutional agreement or a sponsored research agreement — that addresses patent ownership, licensing rights, prosecution responsibilities, and cost-sharing before the research begins. Trying to negotiate these terms after a joint invention has already been made is considerably more difficult, and the leverage dynamics are rarely favorable to the startup.

Assigning Inventor Rights to the Company

Identifying the correct inventors is only the first step — a startup must also ensure that it actually owns the patents that protect its technology. Inventors, by default, own their inventions. The fact that an invention was made in the course of employment, or using company resources, does not automatically transfer ownership to the company under U.S. law. Ownership transfers through a written assignment — a legal document in which the inventor formally transfers their ownership rights to the company. For this reason, it is standard practice — and critically important — for life sciences startups to require all founders, employees, consultants, and contractors to sign invention assignment agreements as a condition of their engagement with the company. These agreements typically provide that any invention made within the scope of the person’s work for the company, or using the company’s resources or confidential information, is automatically assigned to the company upon creation. Without such agreements in place, a departing founder or employee could potentially assert an ownership interest in the startup’s core technology — a scenario that can be devastating to fundraising, partnerships, and acquisitions alike.

Practical Implications for Life Sciences Startups

For a life sciences startup, the distinction between inventorship and authorship has direct practical consequences that are worth anticipating. When a company’s foundational technology is developed in whole or in part at a university or research institution, the inventorship determination will directly affect who owns the resulting patent, most academic institutions have policies that vest ownership of inventions made by their employees in the institution itself, which must then be licensed to the startup. A researcher who qualifies as an inventor but is not properly identified may have a claim to ownership rights that could cloud the startup’s title to its own technology. Academic collaborators who expect authorship credit may also expect inventorship recognition, and managing those expectations early, with clear communication about what each designation means and why the lists may differ, can prevent misunderstandings that damage important relationships. Startups are well advised to involve patent counsel whenever collaborative research is underway, to document the development of inventive concepts carefully, and to revisit the inventorship analysis each time a new patent application is prepared.

This article is part of our Life Sciences Startup IP Resource Center.